Membrane-impermeable estrogen is involved in regulation of calbindin-D9k expression via non-genomic pathways in a rat pituitary cell line, GH3 cells

Toxicology in Vitro

Volumn 24, Issue 4, 2010, Pages 1229-1236

  Dang, Vu Hoang ^a   Choi, Kyung Chul ^a   Jeung, Eui Bae ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Akt pathway; ERK; ERs; G protein; GH3 cell line

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CALBINDIN; ESTROGEN; FULVESTRANT; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PROTEIN KINASE B; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ESTROGEN ACTIVITY; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HYPOPHYSIS CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL; WESTERN BLOTTING;

ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL LINE, TUMOR; ESTROGENS; GENE EXPRESSION REGULATION; PITUITARY NEOPLASMS; RATS;

RATTUS;

EID: 77952953835     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.02.006     Document Type: Article

References (64)

1. Aranda A., Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 2001, 81:1269-1304.
2. Armbrecht H.J., Boltz M., Strong R., Richardson A., Bruns M.E., Christakos S. Expression of calbindin-D decreases with age in intestine and kidney. Endocrinology 1989, 125:2950-2956.
3. Bulayeva N.N., Watson C.S. Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways. Environ. Health Perspect. 2004, 112:1481-1487.
4. Chambliss K.L., Yuhanna I.S., Mineo C., Liu P., German Z., Sherman T.S., Mendelsohn M.E., Anderson R.G., Shaul P.W. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ. Res. 2000, 87:E44-52.
5. Charpentier A.H., Bednarek A.K., Daniel R.L., Hawkins K.A., Laflin K.J., Gaddis S., MacLeod M.C., Aldaz C.M. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res. 2000, 60:5977-5983.
6. Choi K.C., Jeung E.B. The biomarker and endocrine disruptors in mammals. J. Reprod. Dev. 2003, 49:337-345.
7. Choi K.C., Jeung E.B. Molecular mechanism of regulation of the calcium-binding protein calbindin-D9k, and its physiological role(s) in mammals: a review of current research. J. Cell. Mol. Med. 2008, 12:409-420.
8. Christakos S., Gabrielides C., Rhoten W.B. Vitamin D-dependent calcium binding proteins: chemistry, distribution, functional considerations, and molecular biology. Endocr. Rev. 1989, 10:3-26.
9. Dang V.H., Choi K.C., Jeung E.B. Tetrabromodiphenyl ether (BDE 47) evokes estrogenicity and calbindin-D9k expression through an estrogen receptor-mediated pathway in the uterus of immature rats. Toxicol. Sci. 2007, 97:504-511.
10. Dang V.H., Nguyen T.H., Choi K.C., Jeung E.B. A calcium-binding protein, calbindin-D9k, Is regulated through an estrogen-receptor mediated mechanism following xenoestrogen exposure in the GH3 cell line. Toxicol. Sci. 2007, 98:408-415.
11. Dang V.H., Nguyen T.H., Lee G.S., Choi K.C., Jeung E.B. In vitro exposure to xenoestrogens induces growth hormone transcription and release via estrogen receptor-dependent pathways in rat pituitary GH3 cells. Steroids 2009, 74:707-714.
12. Darwish H.M., DeLuca H.F. Identification of a 1,25-dihydroxyvitamin D3-response element in the 5'-flanking region of the rat calbindin D-9k gene. Proc. Natl. Acad. Sci. USA 1992, 89:603-607.
13. Dos Santos E.G., Dieudonne M.N., Pecquery R., Le Moal V., Giudicelli Y., Lacasa D. Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes. Endocrinology 2002, 143:930-940.
14. Dupret J.M., L'Horset F., Perret C., Bernaudin J.F., Thomasset M. Calbindin-D9K gene expression in the lung of the rat. Absence of regulation by 1,25-dihydroxyvitamin D3 and estrogen. Endocrinology 1992, 131:2643-2648.
15. Endoh H., Sasaki H., Maruyama K., Takeyama K., Waga I., Shimizu T., Kato S., Kawashima H. Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem. Biophys. Res. Commun. 1997, 235:99-102.
16. Falkenstein E., Tillmann H.C., Christ M., Feuring M., Wehling M. Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol. Rev. 2000, 52:513-556.
17. Filardo E.J. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J. Steroid Biochem. Mol. Biol. 2002, 80:231-238.
18. Filardo E.J., Quinn J.A., Frackelton A.R., Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 2002, 16:70-84.
19. Frasor J., Barnett D.H., Danes J.M., Hess R., Parlow A.F., Katzenellenbogen B.S. Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology 2003, 144:3159-3166.
20. Fujimoto N., Igarashi K., Kanno J., Honda H., Inoue T. Identification of estrogen-responsive genes in the GH3 cell line by cDNA microarray analysis. J. Steroid Biochem. Mol. Biol. 2004, 91:121-129.
21. Hall J.M., Couse J.F., Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 2001, 276:36869-36872.
22. Hall J.M., McDonnell D.P. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. Mol. Interv. 2005, 5:343-357.
23. Haynes M.P., Sinha D., Russell K.S., Collinge M., Fulton D., Morales-Ruiz M., Sessa W.C., Bender J.R. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ. Res. 2000, 87:677-682.
24. Improta-Brears T., Whorton A.R., Codazzi F., York J.D., Meyer T., McDonnell D.P. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc. Natl. Acad. Sci. USA 1999, 96:4686-4691.
25. Jeung E.B., Krisinger J., Dann J.L., Leung P.C. Molecular cloning of the full-length cDNA encoding the human calbindin-D9k. FEBS Lett. 1992, 307:224-228.
26. Jeung E.B., Leung P.C., Krisinger J. The human calbindin-D9k gene. Complete structure and implications on steroid hormone regulation. J. Mol. Biol. 1994, 235:1231-1238.
27. Kahlert S., Nuedling S., van Eickels M., Vetter H., Meyer R., Grohe C. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J. Biol. Chem. 2000, 275:18447-18453.
28. Katzenellenbogen J.A., Katzenellenbogen B.S. Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses. Chem. Biol. 1996, 3:529-536.
29. Kelly M.J., Levin E.R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 2001, 12:152-156.
30. Kelly M.J., Ronnekleiv O.K. Membrane-initiated estrogen signaling in hypothalamic neurons. Mol. Cell. Endocrinol. 2008, 290:14-23.
31. Keshamouni V.G., Mattingly R.R., Reddy K.B. Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta. J. Biol. Chem. 2002, 277:22558-22565.
32. Krisinger J., Dann J.L., Currie W.D., Jeung E.B., Leung P.C. Calbindin-D9k mRNA is tightly regulated during the estrous cycle in the rat uterus. Mol. Cell. Endocrinol. 1992, 86:119-123.
33. Krisinger J., Setoyama T., Leung P.C. Expression of calbindin-D9k in the early pregnant rat uterus: effects of RU 486 and correlation to estrogen receptor mRNA. Mol. Cell. Endocrinol. 1994, 102:15-22.
34. Kupzig S., Walker S.A., Cullen P.J. The frequencies of calcium oscillations are optimized for efficient calcium-mediated activation of Ras and the ERK/MAPK cascade. Proc. Natl. Acad. Sci. USA 2005, 102:7577-7582.
35. Lee G.S., Choi K.C., Han H.J., Jeung E.B. The classical and a non-classical pathways associated with NF-kappaB are involved in estrogen-mediated regulation of calbindin-D9k gene in rat pituitary cells. Mol. Cell. Endocrinol. 2007, 277:42-50.
36. Leung K.C., Johannsson G., Leong G.M., Ho K.K. Estrogen regulation of growth hormone action. Endocr. Rev. 2004, 25:693-721.
37. Levin E.R. Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 2005, 19:1951-1959.
38. Lim K.T., Cosgrave N., Hill A.D., Young L.S. Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1. Breast Cancer Res. 2006, 8:R33.
39. Marino M., Acconcia F., Ascenzi P. Estrogen receptor signalling: bases for drug actions. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2005, 5:305-314.
40. Marino M., Galluzzo P., Ascenzi P. Estrogen signaling multiple pathways to impact gene transcription. Curr. Genom. 2006, 7:497-508.
41. Mathieu C.L., Mills S.E., Burnett S.H., Cloney D.L., Bruns D.E., Bruns M.E. The presence and estrogen control of immunoreactive calbindin-D9k in the fallopian tube of the rat. Endocrinology 1989, 125:2745-2750.
42. Micevych P.E., Mermelstein P.G. Membrane estrogen receptors acting through metabotropic glutamate receptors: an emerging mechanism of estrogen action in brain. Mol. Neurobiol. 2008, 38:66-77.
43. Nakhla A.M., Khan M.S., Rosner W. Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3',5'-monophosphate. J. Clin. Endocrinol. Metab. 1990, 71:398-404.
44. Nguyen T.H., Lee G.S., Ji Y.K., Choi K.C., Lee C.K., Jeung E.B. A calcium binding protein, calbindin-D9k, is mainly regulated by estrogen in the pituitary gland of rats during estrous cycle. Brain Res. Mol. Brain Res. 2005, 141:166-173.
45. Nie G.Y., Li Y., Wang J., Minoura H., Findlay J.K., Salamonsen L.A. Complex regulation of calcium-binding protein D9k (calbindin-D(9k)) in the mouse uterus during early pregnancy and at the site of embryo implantation. Biol. Reprod. 2000, 62:27-36.
46. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.A. Mechanisms of estrogen action. Physiol. Rev. 2001, 81:1535-1565.
47. Qin C., Samudio I., Ngwenya S., Safe S. Estrogen-dependent regulation of ornithine decarboxylase in breast cancer cells through activation of nongenomic cAMP-dependent pathways. Mol. Carcinog. 2004, 40:160-170.
48. Qiu J., Bosch M.A., Tobias S.C., Grandy D.K., Scanlan T.S., Ronnekleiv O.K., Kelly M.J. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J. Neurosci. 2003, 23:9529-9540.
49. Revelli A., Massobrio M., Tesarik J. Nongenomic actions of steroid hormones in reproductive tissues. Endocr. Rev. 1998, 19:3-17.
50. Roepke T.A., Qiu J., Bosch M.A., Ronnekleiv O.K., Kelly M.J. Cross-talk between membrane-initiated and nuclear-initiated oestrogen signalling in the hypothalamus. J. Neuroendocrinol. 2009, 21:263-270.
51. Sanchez R., Nguyen D., Rocha W., White J.H., Mader S. Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays 2002, 24:244-254.
52. Song R.X., McPherson R.A., Adam L., Bao Y., Shupnik M., Kumar R., Santen R.J. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation. Mol. Endocrinol. 2002, 16:116-127.
53. Tatsumi K., Higuchi T., Fujiwara H., Nakayama T., Itoh K., Mori T., Fujii S., Fujita J. Expression of calcium binding protein D-9k messenger RNA in the mouse uterine endometrium during implantation. Mol. Hum. Reprod. 1999, 5:153-161.
54. Tokunaga E., Kimura Y., Mashino K., Oki E., Kataoka A., Ohno S., Morita M., Kakeji Y., Baba H., Maehara Y. Activation of PI3K/Akt signaling and hormone resistance in breast cancer. Breast Cancer 2006, 13:137-144.
55. Turner R.T., Riggs B.L., Spelsberg T.C. Skeletal effects of estrogen. Endocr. Rev. 1994, 15:275-300.
56. Vasudevan N., Pfaff D.W. Membrane-initiated actions of estrogens in neuroendocrinology: emerging principles. Endocr. Rev. 2007, 28:1-19.
57. Watanabe H., Suzuki A., Kobayashi M., Takahashi E., Itamoto M., Lubahn D.B., Handa H., Iguchi T. Analysis of temporal changes in the expression of estrogen-regulated genes in the uterus. J. Mol. Endocrinol. 2003, 30:347-358.
58. Watson C.S., Bulayeva N.N., Wozniak A.L., Alyea R.A. Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids 2007, 72:124-134.
59. Watson C.S., Pappas T.C., Gametchu B. The other estrogen receptor in the plasma membrane: implications for the actions of environmental estrogens. Environ. Health Perspect. 1995, 103(Suppl. 7):41-50.
60. Watters J.J., Chun T.Y., Kim Y.N., Bertics P.J., Gorski J. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells. Mol. Endocrinol. 2000, 14:1872-1881.
61. Williams K., McKinnell C., Saunders P.T., Walker M., Fisher J.S., Turner K.J., Atanassova N., Sharpe M. Neonatal exposure to potent and environmental oestrogens and abnormalities of the male reproductive system in the rat: evidence for importance of the androgen-oestrogen balance and assessment of the relevance to man. Hum. Reprod. Update 2001, 7:236-247.
62. Yager J.D. Endogenous estrogens as carcinogens through metabolic activation. J. Natl. Cancer Inst. Monogr. 2000, 67:73.
63. Zhang L., Li X., Zhao L., Zhang L., Zhang G., Wang J., Wei L. Nongenomic effect of estrogen on the MAPK signaling pathway and calcium influx in endometrial carcinoma cells. J. Cell. Biochem. 2009, 106:553-562.
64. Zhang Z., Kumar R., Santen R.J., Song R.X. The role of adapter protein Shc in estrogen non-genomic action. Steroids 2004, 69:523-529.